InspireMD Inc (NSPR) USD0.0001

Sell:$2.50Buy:$2.83$0.16 (5.76%)

Prices delayed by at least 15 minutes
Sell:$2.50
Buy:$2.83
Change:$0.16 (5.76%)
Prices delayed by at least 15 minutes
Sell:$2.50
Buy:$2.83
Change:$0.16 (5.76%)
Prices delayed by at least 15 minutes

Company Information

About this company

InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Key people

Marvin L. Slosman
President, Chief Executive Officer, Director
Craig Shore
Chief Financial Officer, Treasurer, Company Secretary
Andrea Tommasoli
Chief Operating Officer
Amir Kohen
Vice President - Finance, Human Resources
Shane Gleason
Vice President - Global Marketing, General Manager, North America
Paul S. Stuka
Independent Chairman of the Board
Scott R. Ward
Director
Kathryn Arnold
Independent Director
Michael Berman
Independent Director
Thomas J. Kester
Independent Director
Click to see more

Key facts

  • EPIC
    NSPR
  • Location
    Israel
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US45779A8466
  • Market cap
    $80.16m
  • Employees
    85
  • Shares in issue
    29.69m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.